London Daily

Focus on the big picture.
Thursday, Dec 18, 2025

UK approves another antibody treatment for Covid

UK approves another antibody treatment for Covid

The UK has approved another antibody treatment for people with Covid that cuts the risk of severe illness.

It's called sotrovimab, and scientists say preliminary checks suggest it should work well even against new variants such as Omicron.

The drug, given in a drip into a vein, binds to the virus to stop it entering our cells.

In a clinical trial, a single dose reduced the risk of hospitalisation and death by 79% in high risk adults.

It is the second drug of its kind - a monoclonal antibody treatment - that UK regulators have approved.

Both sotrovimab and the other approved antibody treatment, ronapreve, are most effective when taken during the early stages of infection. The Medicines and Healthcare products Regulatory Agency (MHRA) recommends they are used within five days of someone getting symptoms.

Dr June Raine, MHRA chief executive, said: "This is yet another therapeutic that has been shown to be effective at protecting those most vulnerable to Covid-19, and signals another significant step forward in our fight against this devastating disease."

Drug company GSK, which made sotrovimab (Xevudy), says it has run some early tests in the lab to see how well the treatment fares against the new, heavily mutated Covid variant Omicron that is now spreading around the world.

More checks are needed, but researchers say the drug targets a part of the spike protein of the virus that has not yet undergone big changes or mutations, meaning it should work well.

Henny Braund, chief executive of cancer charity Anthony Nolan, said: "This is positive news for blood cancer patients, who we know are less likely to be protected from Covid-19 vaccines than the wider population. It is particularly important that patients can access this treatment immediately, if they contract the virus, and there is clear guidance for doctors on making it available."

What treatments do we have against Covid?


Aside from vaccines that are designed to help prevent infections happening in the first place, as well as cut the risk of getting very ill, there are a few different types of treatments for Covid.

They fall into three main categories:

* Antibodies that can target the virus, taken from either survivors' blood plasma or made in a lab (such as sotrovimab and ronapreve)

* Antiviral pills, such as molnupiravir, that directly affect the coronavirus's ability to thrive inside the body

* Drugs, such as dexamethasone, that calm the immune system

Most people who have Covid do not need any treatment and will recover within a few weeks. You may be able to look after yourself at home. Some of the same things you do to feel better if you have the flu - resting, drinking enough fluids and taking paracetamol or ibuprofen - can help.

If you become more unwell then you should seek medical help.

People who think they may have Covid should get a test and self-isolate to help stop the virus spreading.

Newsletter

Related Articles

0:00
0:00
Close
UK Issues Final Ultimatum to Roman Abramovich Over £2.5bn Chelsea Sale Funds for Ukraine
Rare Pink Fog Sweeps Across Parts of the UK as Met Office Warns of Poor Visibility
UK Police Pledge ‘More Assertive’ Enforcement to Tackle Antisemitism at Protests
UK Police Warn They Will Arrest Protesters Chanting ‘Globalise the Intifada’
Trump Files $10 Billion Defamation Lawsuit Against BBC as Broadcaster Pledges Legal Defence
UK Says U.S. Tech Deal Talks Still Active Despite Washington’s Suspension of Prosperity Pact
UK Mortgage Rules to Give Greater Flexibility to Borrowers With Irregular Incomes
UK Treasury Moves to Position Britain as Leading Global Hub for Crypto Firms
U.S. Freezes £31 Billion Tech Prosperity Deal With Britain Amid Trade Dispute
Prince Harry and Meghan’s Potential UK Return Gains New Momentum Amid Security Review and Royal Dialogue
Zelensky Opens High-Stakes Peace Talks in Berlin with Trump Envoy and European Leaders
Historical Reflections on Press Freedom Emerge Amid Debate Over Trump’s Media Policies
UK Boosts Protection for Jewish Communities After Sydney Hanukkah Attack
UK Government Declines to Comment After ICC Prosecutor Alleges Britain Threatened to Defund Court Over Israel Arrest Warrant
Apple Shutters All Retail Stores in the United Kingdom Under New National COVID-19 Lockdown
US–UK Technology Partnership Strains as Key Trade Disagreements Emerge
UK Police Confirm No Further Action Over Allegation That Andrew Asked Bodyguard to Investigate Virginia Giuffre
Giuffre Family Expresses Deep Disappointment as UK Police Decline New Inquiry Into Andrew Mountbatten-Windsor Claims
Transatlantic Trade Ambitions Hit a Snag as UK–US Deal Faces Emerging Challenges
Ex-ICC Prosecutor Alleges UK Threatened to Withdraw Funding Over Netanyahu Arrest Warrant Bid
UK Disciplinary Tribunal Clears Carter-Ruck Lawyer of Misconduct in OneCoin Case
‘Pink Ladies’ Emerge as Prominent Face of UK Anti-Immigration Protests
Nigel Farage Says Reform UK Has Become Britain’s Largest Party as Labour Membership Falls Sharply
Google DeepMind and UK Government Launch First Automated AI Lab to Accelerate Scientific Discovery
UK Economy Falters Ahead of Budget as Growth Contracts and Confidence Wanes
Australia Approves Increased Foreign Stake in Strategic Defence Shipbuilder
Former UK Prime Minister Boris Johnson proclaims, “For Ukraine, surrendering their land would be a nightmare.”
Microsoft Challenges £2.1 Billion UK Cloud Licensing Lawsuit at Competition Tribunal
Fake Doctor in Uttar Pradesh Accused of Killing Woman After Performing YouTube-Based Surgery
Hackers Are Hiding Malware in Open-Source Tools and IDE Extensions
Traveling to USA? Homeland Security moving toward requiring foreign travelers to share social media history
UK Officials Push Back at Trump Saying European Leaders ‘Talk Too Much’ About Ukraine
UK Warns of Escalating Cyber Assault Linked to Putin’s State-Backed Operations
UK Consumer Spending Falters in November as Households Hold Back Ahead of Budget
UK Orders Fresh Review of Prince Harry’s Security Status After Formal Request
U.S. Authorises Nvidia to Sell H200 AI Chips to China Under Security Controls
Trump in Direct Assault: European Leaders Are Weak, Immigration a Disaster. Russia Is Strong and Big — and Will Win
"App recommendation" or disguised advertisement? ChatGPT Premium users are furious
"The Great Filtering": Australia Blocks Hundreds of Thousands of Minors From Social Networks
Mark Zuckerberg Pulls Back From Metaverse After $70 Billion Loss as Meta Shifts Priorities to AI
Nvidia CEO Says U.S. Data-Center Builds Take Years while China ‘Builds a Hospital in a Weekend’
Indian Airports in Turmoil as IndiGo Cancels Over a Thousand Flights, Stranding Thousands
Hollywood Industry on Edge as Netflix Secures Near-$60 Bln Loan for Warner Bros Takeover
Drugs and Assassinations: The Connection Between the Italian Mafia and Football Ultras
Hollywood megadeal: Netflix acquires Warner Bros. Discovery for 83 billion dollars
The Disregard for a Europe ‘in Danger of Erasure,’ the Shift Toward Russia: Trump’s Strategic Policy Document
Two and a Half Weeks After the Major Outage: A Cloudflare Malfunction Brings Down Multiple Sites
UK data-regulator demands urgent clarity on racial bias in police facial-recognition systems
Labour Uses Biscuits to Explain UK Debt — MPs Lean Into Social Media to Reach New Audiences
German President Lays Wreath at Coventry as UK-Germany Reaffirm Unity Against Russia’s Threat
×